The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
*de risked
Plenty of news due. Absolute bargain and perished.
Nice momentum
Absolutely
4p chance going soon someone building fast
How do you think they'll handle it slick ? Wait for a couple more milestones to get us in double figures... don't think partners will invest without getting some of the company but due to being holders higher up like us I don't think they'll insist on big dilution.
I guess when funds are in the bag already he doesn't need to over egg it and maybe under achieve. Once we have 2 to 3 more systems take up then that's this year met and will prove viable to the market.
200m?
How much would a profitable polarean be? 2027 hopefully. If its still an Independent company
Great that Philips and polarean are working in tandem like that. Find it strange why Philips not come straight out with an offer for the company... 20-40p should meet with shareholder approval. Making it 40-80m purchase... mu mind says more but with current weakness that would do it
Well done. Bit of short term commercial news should see us back to double figures realistically. Any time now. Hard to be patient but we must as proven that has been shown as the most important quality to profit in the stock market
Yes brilliant. Imagine the conversations and potential flow of uptake. We know 3 are pending.. but how many at different stages. Put yourself in the clinician position its not an hard sell the fact that you're not frying with radiation ongoing and can do harmless repeats and monitoring of condition progress.
Polarean gets first de novo order for Xenoview polariser
By Sharecast News
Sharecast News | 07 Dec, 2023
09:50 04/03/24
4.15
-2.35%-0.10
Max: 4.50
Min: 4.00
Volume: 665,350
MM 200 : 13.31
Lung-focussed MRI technology developer Polarean Imaging said in an update on Thursday that it has received its first de novo order for a new Xenoview polariser.
The AIM-traded firm said it had secured its first de novo polariser order from a top US academic medical centre, with ongoing negotiations with other institutions.
Efforts to boost clinical use continued at the University of Cincinnati Children's Hospital Medical Center and the University of Missouri Health Care.
Polarean added that its new reimbursement APC-code from the US Centers for Medicare & Medicaid Services offered an improved economic incentive for hospitals.
Elsewhere, Polarean said collaborations with Philips were advancing, with training sessions and plans to introduce Xenoview MRI to Philips' customer base.
Polarean also sponsored a clinical trial in collaboration with a nebuliser device manufacturer to evaluate aerosol drug delivery technologies.
The company was also making progress on expanding Xenoview MRI's age range for children and its indications for pulmonary and cardio-pulmonary diseases.
Finally, Polarean said its current cash runway was expected to last until the third quarter of 2024, with ongoing evaluation of financing options.
"We are delighted to have received our first de novo polariser order from a top-tier academic medical centre, and we look forward to working closely with them to establish the use of Xenoview for their patients living with lung disease," said chief executive officer Christopher von Jako.
"As previously stated, establishing orders for new imaging technologies often takes time, even when clinicians are highly motivated to adopt the technology.
"We continue to have positive meetings with other high priority centres as they work through their budget cycle and value analysis processes, as well our already converted centres and those we expect to convert in 2024, to encourage increased utilisation of the technology in clinic."
Von Jako said the company had made substantial progress in all other areas of the growth initiatives it established in its interim results.
"I believe that we are setting the correct foundations to enable the Xenoview technology to be a commercial success.
"While we are assessing various financing options, I am confident that we will be able to finance the company for the medium term, and would like to extend my thanks to our strategic investors for their continued strong support
At 1535 GMT, shares in Polarean Imaging were up 27.94% at 6.33p.
And up
A few happy to pile in at this price. If no seller should be on the way up soon
We all Need the comfort blanky. It's difficult when shares get battered. More than necessary. Markets don't like doubt. That rns took away a lot of doubt. We need more commercial news this month I feel. Or before end of April.
I hope you're right slick. Get to a pound and I'll be able to retire. 50p and I'm taking it steady. At 4.5p near bankrupt lol. Hey ho it will be sweet when we get moving and next commercial deal. Soon I'm expecting. But even Duke has the budget red tape as bastian said to me
Likewise I had most of mine around 15p then some at 10p. Then equal amount at 4.7p still in a dire underwater realm . But if you believe you believe. I so nearly did a trade at 17.5 on code spike. But thought was another couple of pence in it on day . Then they tool it down. So missing a profit isn't great again. But I do have a longer term view than trading. But if this spiked strangely historically worth trying to catch it . To sell not buy
It's bad but not that bad within the spread most of the time. I jumped in with usual optimism too early. At 4.7p doubling my holding. I have way too many of these when thru drop. Not enough when it goes up... I really did expect survival and money and support to take us into the blue yesterday. Called that wrong. But hey ho IMHO bargain basement shares.
Yes I do agree slick. We were due that tick up some strong buying from what I see as a golden overdone opportunity.